References
- Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B hepatitis genome. Science 1989; 244: 359–362
- Kuo, G, Choo, QL, Alter, HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–364
- Kao N, Hijikata M, Ootsuyama Y, Nakiawa M, Ohikoshi S, Sugimura T, Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990; 87: 9524–9528
- Alter, HJ, Purcell, RH, Shih, JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–1500
- Esteban, JL, Esteban, R, Viladomiu, L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; ii: 294–296
- Remeo R, Thiers V, Driss F, Berthelot P, Nalpas B, Breschot C. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels. Transfusion 1993; 33: 629–633
- Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene of isolates collected worldwide. Proc Natl Acad Sci, USA 1993; 90: 8234–8238
- Mori S, Kato N, Yagyu A, Tanaka T, Ikeda Y, Petchclai B, Chiewsilp P, Kurimura T, Shimotohno K. A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun 1992; 183: 334–342
- Okamoto H, Kurai K, Okada S, Yamamoto K, Iizuka H, Tanaka T, Fukuda S, Tsuda F, Mishiro S. Full length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992b; 188: 331–341
- Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka K, Sato K, Tsuda F, Miyakawa Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992d; 73: 673–679
- Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, Mishiro S. Characterization of the genomic sequence of Type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993; 74: 2385–2390
- Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follette E, Yap PL, Simmonds P. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131–1141
- Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA, Holmes EC. Sequence variability in the 5′non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74: 661–668
- Stuyver L, Rossau T, Wyseur A, Duhamei M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093–1102
- Cha TA, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Nat Acad Sci, USA 1992; 89: 7144–7148
- Okamoto H, Sugiyama Y, Okada SI, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992b; 73: 673–679
- Takada N, Takase S, Takoda A, Date T. HCV genotypes in different countries. Lancet 1992; 339–339, 808
- Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992; 16: 619–624
- Yoshioka, K, Kakumu, S, Wakita, T, Ishikawa, T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293–294
- Chomeznski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 1987; 162: 156–159
- Kanai K, Iwata K, Nakao M, Okamoto H. Suppression of hepatitis C virus RNA by interferon-α. Lancet 1990; 336: 245–245
- Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M. Detection of hepatitis C virus by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990; 60: 215–222
- Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237–238
- Esteban, JL, Lopez-Talavera, JC, Genesca, J, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitic C virus. Ann Intern Med 1991; 13: 256–259
- Kuperan P, Aw TC, Ding SH, Lee G. Prevalence of antibodies to hepatitic C virus in relation to surrogate markers in a blood donor population of Singapore. Southeast Asian J Trop Med Public Health 1993; 24(Suppl 1)127–129
- Tokita, H, Shrestha, SM, Okamoto, H, Sakamoto, M, et al. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol 1994; 75: 931–936